Amyotropic Lateral Sclerosis (ALS) clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
open to eligible people ages 12 years and up
The primary purpose of this study is to evaluate the clinical efficacy of ION363 on clinical function and survival in carriers of fused in sarcoma mutations with amyotrophic lateral sclerosis (FUS-ALS).
at UCSD
Last updated: